
Amrutanjan Q2 FY27: PAT up 24% YoY to ₹17.3 Cr as margins expand, hygiene turns profitable
Amrutanjan's standalone revenue from operations rose 14.9% YoY to ₹135.18 Cr in Q2 FY27 (quarter ended 30 September 2026), while net profit grew faster at 23.8% YoY to ₹17.28 Cr, lifting net profit margin to 12.78% from 11.86% a year earlier. Both the current and year-ago quarters are clean of exceptional items, so this YoY comparison is like-for-like — unlike the sequential print, where Q1 FY27 (June quarter) carried a ₹2.03 Cr exceptional charge (one-time settlement of a decades-old Tamil Nadu lease-rent dispute) that depressed that quarter's PAT to ₹4.37 Cr. The resulting +296% QoQ PAT jump is a base-effect artifact of that one-off and should not be read as the quarter's story; the 14.9% revenue / 23.8% PAT YoY print is the cleaner read. The margin expansion was driven by the core OTC portfolio and a turnaround in Women's Hygiene & Personal Care: OTC segment profit rose 26.5% YoY to ₹23.29 Cr on revenue of ₹90.94 Cr (+13.7% YoY), while Women's Hygiene swung to a ₹0.46 Cr segment profit from a ₹1.26 Cr loss a year ago and a ₹2.88 Cr loss last quarter — its first profitable quarter in this comparison window. Operating margin (ex-other income, ex-exceptional items) expanded to 14.85% from 12.68% YoY. Beverages was the drag: revenue fell 29.4% YoY to ₹3.03 Cr and its segment loss widened to ₹2.41 Cr from ₹0.65 Cr a year ago, continuing a decline already visible last quarter. The effective tax rate also eased to 25.2% from 27.3% YoY, helping PAT growth outpace PBT growth of 20.2% YoY. No analyst consensus or brokerage preview for this quarter surfaced in a web search, and the company has issued no formal forward guidance in our records or online, so there is no external yardstick this print beat or missed — both vsStreet and vsGuidance are unknown. No management press release accompanied this filing. Alongside the results, the board declared a First Interim Dividend of ₹1 per share for FY27, consistent with its regular payout cadence (it had approved a ₹2.90 final dividend for FY26 at the September 2026 AGM).
Key Highlights
- Standalone revenue +14.9% YoY to ₹135.18 Cr; PAT +23.8% YoY to ₹17.28 Cr (basic EPS ₹5.98 vs ₹4.83 YoY)
- NPM expanded to 12.78% from 11.86% YoY; OPM to 14.85% from 12.68% YoY — both periods clean of exceptional items
- Women's Hygiene & Personal Care segment turned profitable (+₹0.46 Cr) vs a ₹1.26 Cr loss YoY and ₹2.88 Cr loss last quarter
- OTC Products segment profit +26.5% YoY to ₹23.29 Cr on 13.7% revenue growth (₹90.94 Cr) — still ~67% of total revenue
- Beverages segment loss widened to ₹2.41 Cr (from ₹0.65 Cr YoY) on a 29.4% revenue decline
- QoQ PAT comparison (+296%) is a base-effect artifact — Q1 FY27 carried a ₹2.03 Cr one-time exceptional charge for a Tamil Nadu lease-rent settlement
- Board declared First Interim Dividend of ₹1/share for FY27 alongside results
Price Impact
More from AMRUTANJAN